Semaphorin‑4C is upregulated in epithelial ovarian cancer

  • Authors:
    • Shaoyan Huang
    • Shan Han
    • Jianzhong Zhang
    • Zhaokun Zhong
    • Jianrong Wang
  • View Affiliations

  • Published online on: March 3, 2020     https://doi.org/10.3892/ol.2020.11444
  • Pages: 3333-3338
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present retrospective study aimed to investigate the expression of semaphorin‑4C (Sema4C) in epithelial ovarian cancer (EOC), and to determine the association between Sema4C expression and patient clinicopathological characteristics. Sema4C mRNA expression was detected by reverse transcription‑quantitative polymerase chain reaction in the tissues of 74 cases of EOC, 20 cases of ovarian epithelial benign tumor, 20 cases of ovarian borderline epithelial tumor and 15 cases of normal ovarian tissue. Immunohistochemistry was used to detect the expression and localization of Sema4C. The association between Sema4C expression level and patients clinicopathological characteristics was determined by χ2 test. The results demonstrated that Sema4C expression level in ovarian epithelial carcinoma tissues was significantly higher compared with that in benign tumors, borderline epithelial tumors and normal ovarian tissues (P<0.05). In addition, Sema4C expression in ovarian cancer tissues was significantly associated with the clinical and pathological stages of tumors (P<0.05). In conclusion, the present study demonstrated that Sema4C expression was upregulated in EOC.
View Figures
View References

Related Articles

Journal Cover

April-2020
Volume 19 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Huang S, Han S, Zhang J, Zhong Z and Wang J: Semaphorin‑4C is upregulated in epithelial ovarian cancer. Oncol Lett 19: 3333-3338, 2020
APA
Huang, S., Han, S., Zhang, J., Zhong, Z., & Wang, J. (2020). Semaphorin‑4C is upregulated in epithelial ovarian cancer. Oncology Letters, 19, 3333-3338. https://doi.org/10.3892/ol.2020.11444
MLA
Huang, S., Han, S., Zhang, J., Zhong, Z., Wang, J."Semaphorin‑4C is upregulated in epithelial ovarian cancer". Oncology Letters 19.4 (2020): 3333-3338.
Chicago
Huang, S., Han, S., Zhang, J., Zhong, Z., Wang, J."Semaphorin‑4C is upregulated in epithelial ovarian cancer". Oncology Letters 19, no. 4 (2020): 3333-3338. https://doi.org/10.3892/ol.2020.11444